tetrakis-mu-acetylsalicylato-dicopper(ii) has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZH; Liu, WP; Ma, GY; Shen, ZQ; Wang, DC; Wu, WL; Xiong, HZ; Yang, YK | 1 |
1 other study(ies) available for tetrakis-mu-acetylsalicylato-dicopper(ii) and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Inhibitory effects of copper-aspirin complex on platelet aggregation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Serotonin; Thromboxane B2 | 1997 |